Quintessence Biosciences benefits from expansion of investment tax credits
Quintessence Biosciences, one of the first biotechnology companies in Wisconsin to benefit from the expansion of the investor tax credit program this past February. Wisconsin has had tax credits available to investors in early-stage technology companies since the 2004 passage of Act 255.The BioForward government...